Home > Income Statement > DIVIS LABORATORIES

DIVIS LABORATORIES
Consolidated Net Profit

    Back to Income Statement
DIVIS LABORATORIES is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
COMMUNITY POLL
for DIVIS LABORATORIES
Please provide your vote to see the results

DIVIS LABORATORIES Last 5 Year Consolidated Net Profit History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Consolidated Net Profit ₹1,600 Cr₹1,824 Cr₹2,960 Cr₹1,984 Cr₹1,377 Cr

What is the latest Consolidated Net Profit of DIVIS LABORATORIES ?

The latest Consolidated Net Profit ratio of DIVIS LABORATORIES is ₹1,600 Cr based on Mar2024 Consolidated results.
Year Consolidated Net Profit
Mar2024₹1,600 Cr
Mar2023₹1,824 Cr
Mar2022₹2,960 Cr
Mar2021₹1,984 Cr
Mar2020₹1,377 Cr

How is Consolidated Net Profit of DIVIS LABORATORIES Trending?

Years Consolidated Net Profit % Change
Mar2024 ₹1,600 Cr
-12.28
Mar2023 ₹1,824 Cr
-38.39
Mar2022 ₹2,960 Cr
49.19
Mar2021 ₹1,984 Cr
44.15
Mar2020 ₹1,377 Cr -

Compare Consolidated Net Profit of peers of DIVIS LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
DIVIS LABORATORIES ₹158,673.4 Cr 2.4% 2.2% 59.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹400,617.0 Cr -2.1% -9% 9.1% Stock Analytics
CIPLA ₹119,511.0 Cr 1.4% 2% 0.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹104,734.0 Cr -0.9% -2.8% 16.8% Stock Analytics
DR REDDYS LABORATORIES ₹97,705.1 Cr -2.1% -9.2% -8.7% Stock Analytics
MANKIND PHARMA ₹96,821.9 Cr -2.1% -10.9% 7.9% Stock Analytics


DIVIS LABORATORIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
DIVIS LABORATORIES

2.4%

2.2%

59.7%

SENSEX

-0.4%

-1.4%

5.4%


You may also like the below Video Courses